Lv1
68 积分 2023-11-04 加入
Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event
8天前
已完结
Prevalence of Silent Atherosclerosis across Adult Life
8天前
已完结
Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis
8天前
已完结
Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
8天前
已完结
Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease
8天前
已完结
Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients
9天前
已完结
Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
10天前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
10天前
已完结
LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction
10天前
已完结
Eplontersen for Transthyretin Amyloid Cardiomyopathy
10天前
已完结
Headache research 2025: trials, mechanisms, and biomarkers
皖公网安备34019202002308
